These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29945742)

  • 21. Association of Major Adverse Cardiac Events and Beta-Blockers in Patients with and without Atherosclerotic Cardiovascular Disease: Long-Term Follow-Up Results of the T-SPARCLE and T-PPARCLE Registry in Taiwan.
    Liu PY; Lin FJ; Yeh CF; Hsiao YC; Hsuan CF; Chang WT; Kao HL; Jeng JS; Wu YW; Hsieh IC; Fang CC; Wang KY; Chang KC; Lin TH; Sheu WH; Li YH; Yin WH; Yeh HI; Chen JW; Wu CC;
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study.
    Nakano T; Tanaka S; Tsuruya K; Kitazono T
    Clin Exp Nephrol; 2021 Apr; 25(4):385-393. PubMed ID: 33398604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of chronic kidney disease and end-stage renal disease on the mid-term adverse outcomes in diabetic patients with cardiovascular diseases.
    Chou CL; Chiu HW; Hsu YH; Yu SM; Liou TH; Sung LC
    Sci Rep; 2024 Jul; 14(1):15770. PubMed ID: 38982230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of statins for the primary prevention of cardiovascular disease in the Asian elderly population.
    Lin YW; Wang CC; Wu CC; Hsu YT; Lin FJ
    Int J Cardiol; 2023 Feb; 373():25-32. PubMed ID: 36435332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2022 Taiwan lipid guidelines for primary prevention.
    Huang PH; Lu YW; Tsai YL; Wu YW; Li HY; Chang HY; Wu CH; Yang CY; Tarng DC; Huang CC; Ho LT; Lin CF; Chien SC; Wu YJ; Yeh HI; Pan WH; Li YH;
    J Formos Med Assoc; 2022 Dec; 121(12):2393-2407. PubMed ID: 35715290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease.
    Zhao Y; Xiang P; Coll B; López JAG; Wong ND
    J Diabetes Complications; 2021 Mar; 35(3):107767. PubMed ID: 33168394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease.
    Navaneethan SD; Hegbrant J; Strippoli GF
    Curr Opin Nephrol Hypertens; 2011 Mar; 20(2):146-52. PubMed ID: 21245764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy.
    Ridker PM; Tuttle KR; Perkovic V; Libby P; MacFadyen JG
    Eur Heart J; 2022 Dec; 43(46):4832-4844. PubMed ID: 35943897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?
    Gregg LP; Hedayati SS
    Am J Kidney Dis; 2018 Nov; 72(5):728-744. PubMed ID: 29478869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the 2021 European Society for Cardiology prevention guideline's stepwise approach for cardiovascular risk factor treatment in patients with established atherosclerotic cardiovascular disease.
    Holtrop J; Bhatt DL; Ray KK; Mach F; Smulders YM; Carballo D; Steg PG; Visseren FLJ; Dorresteijn JAN
    Eur J Prev Cardiol; 2024 Apr; 31(6):754-762. PubMed ID: 38324720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study.
    Kuo CS; Kuo NR; Yeh YK; Lee YJ; Chuang LM; Chen HF; Chen CC; Lee CC; Hsu CC; Li HY; Ou HY; Hwu CM
    Lipids Health Dis; 2024 Jan; 23(1):24. PubMed ID: 38263010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of Statins as Secondary Prevention Against Recurrent and Terminal Major Adverse Cardiovascular Events.
    Tecson KM; Kluger AY; Cassidy-Bushrow AE; Liu B; Coleman CM; Jones LK; Jefferson CR; VanWormer JJ; McCullough PA
    Am J Cardiol; 2022 Aug; 176():37-42. PubMed ID: 35606173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology.
    Pontremoli R; Bellizzi V; Bianchi S; Bigazzi R; Cernaro V; Del Vecchio L; De Nicola L; Leoncini G; Mallamaci F; Zoccali C; Buemi M
    J Nephrol; 2020 Jun; 33(3):417-430. PubMed ID: 32065354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of LDL Cholesterol on Microvascular Versus Macrovascular Disease: A Mendelian Randomization Study.
    Emanuelsson F; Nordestgaard BG; Tybjærg-Hansen A; Benn M
    J Am Coll Cardiol; 2019 Sep; 74(11):1465-1476. PubMed ID: 31514949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using Machine Learning to Evaluate the Role of Microinflammation in Cardiovascular Events in Patients With Chronic Kidney Disease.
    Liu XQ; Jiang TT; Wang MY; Liu WT; Huang Y; Huang YL; Jin FY; Zhao Q; Wang GH; Ruan XZ; Liu BC; Ma KL
    Front Immunol; 2021; 12():796383. PubMed ID: 35082785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A risk stratification model modified from the U.S. guideline could be applied in an Asian population with or without ASCVD: Validation study.
    Hsiao YC; Lee TL; Lin FJ; Hsuan CF; Yeh CF; Chang WT; Kao HL; Jeng JS; Wu YW; Hsieh IC; Fang CC; Wang KY; Chang KC; Lin TH; Sheu WH; Li YH; Yin WH; Yeh HI; Chen JW; Wu CC;
    Biomed J; 2024 Jun; 47(3):100653. PubMed ID: 37579816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lipid story in chronic kidney disease: a long story with a happy end?
    Kujawa-Szewieczek A; Więcek A; Piecha G
    Int Urol Nephrol; 2013 Oct; 45(5):1273-87. PubMed ID: 23054316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
    Cherney DZI; Repetto E; Wheeler DC; Arnold SV; MacLachlan S; Hunt PR; Chen H; Vora J; Kosiborod M
    Am J Nephrol; 2020; 51(1):74-82. PubMed ID: 31812955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and chronic complication profiles among patients with chronic kidney disease in Alberta, Canada: a retrospective observational study.
    Lau DCW; Shaw E; McMullen S; Cowling T; Witges K; Amitay EL; Steubl D; Girard LP
    BMC Nephrol; 2024 Jul; 25(1):244. PubMed ID: 39080608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher risk of future events, mortality and greater healthcare use among patients with increasingly recurrent atherosclerotic cardiovascular disease events in Taiwan: a retrospective cohort study.
    Hsu CY; Chen WJ; Lin HJ; Chen HM; Yang YH; Chen WJ; Chen CM; Hsiao FY
    BMJ Open; 2023 Jul; 13(7):e064219. PubMed ID: 37474164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.